1

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

esgxokp7jrn9
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis. with only around 5% of patients surviving for a period of 5 years or more after diagnosis. Despite aggressive multimodal therapy. consisting mostly of a combination of surgery. https://mainlandskateandsurfes.shop/product-category/mens-dress-shirts/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story